` RGIN (Regenicin Inc) vs S&P 500 Comparison - Alpha Spread

R
RGIN
vs
S&P 500

Over the past 12 months, RGIN has significantly outperformed S&P 500, delivering a return of +100% compared to the S&P 500's +14% growth.

Stocks Performance
RGIN vs S&P 500

Loading
RGIN
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
RGIN vs S&P 500

Performance Gap Between RGIN and GSPC
HIDDEN
Show

Performance By Year
RGIN vs S&P 500

Loading
RGIN
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Regenicin Inc vs Peers

S&P 500
RGIN
AMGN
ARGX
ALNY
603259
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Regenicin Inc
Glance View

Market Cap
30.7k USD
Industry
N/A

Regenicin, Inc. is a biotechnology company, which specializes in the development of regenerative cell therapies to restore the health of damaged tissues and organs. The company is headquartered in Little Falls, New Jersey. The company went IPO on 2008-05-12. The firm is focused on developing and commercializing a lifesaving technology by the introduction of tissue-engineered skin substitutes to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds and a range of plastic surgery procedures. Its product, NovaDerm, is a multi-layered tissue-engineered skin prepared by utilizing autologous skin cells. NovaDerm is a graftable cultured epithelium skin substitute containing both epidermal and dermal components. The firm is focused on developing its product, TempaDerm. TempaDerm cells develop banks of cryo-preserved (frozen) cells and cultured skin substitute to provide a continuous supply of non-allogenic skin substitutes to treat smaller wound areas on patients, such as ulcers. Its application are used for treatment of chronic skin wounds.

RGIN Intrinsic Value
Not Available
Back to Top